Tazarotene, commonly marketed as Tazorac, Avage, and Zorac is member of the acetylenic class of Retinoids: A Review

Mayur S. Jain; Shashikant D. Barhate

doi:10.5958/2231-5691.2019.00034.0

Asian Journal of Pharmaceutical Research

ISSN

2231-5691 (Online)
2231-5683 (Print)

Submit Article

Tazarotene, commonly marketed as Tazorac, Avage, and Zorac is member of the acetylenic class of Retinoids: A Review

Author(s): Mayur S. Jain, Shashikant D. Barhate

Email(s): mayurjain176@gmail.com

DOI: 10.5958/2231-5691.2019.00034.0

Address: Mayur S. Jain*, Dr. Shashikant D. Barhate1
1Shree Sureshdada Jain Institute of Pharmaceutical Education and Research, Jammer.
*Corresponding Author

Published In: Volume - 9, Issue - 3, Year - 2019

Keywords:

Cite this article:
Mayur S. Jain, Shashikant D. Barhate. Tazarotene, commonly marketed as Tazorac, Avage, and Zorac is member of the acetylenic class of Retinoids: A Review. Asian J. Pharm. Res. 2019; 9(3):206-208. doi: 10.5958/2231-5691.2019.00034.0

View PDF

Recomonded Articles:

A Review- Ceftriaxone for Life

Author(s): Mohd. Yaqub Khan, Maryada Roy, Raj Kumar Rawal, Umesh Kumar Bansal

DOI: 10.5958/2231-5691.2017.00007.7 Access: Open Access Read More

Tazarotene, commonly marketed as Tazorac, Avage, and Zorac is member of the acetylenic class of Retinoids: A Review

Author(s): Mayur S. Jain, Shashikant D. Barhate

DOI: 10.5958/2231-5691.2019.00034.0 Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available
DOI: 10.5958/2231–5691